Decreased Inpatient Mortality in Obese Patients with Abdominal Nets
- PMID: 25100391
- DOI: 10.4158/EP14203.OR
Decreased Inpatient Mortality in Obese Patients with Abdominal Nets
Abstract
Background: Neuroendocrine tumors (NETs) of the abdomen are rare tumors with an incidence of 3.56 per 100,000 in the general population. Obesity is a growing public health problem with varying effects on severity of other disease. We investigated the association between obesity and inpatient morbidity/mortality in patients with abdominal neuroendocrine tumors utilizing the Nationwide Inpatient Sample (NIS).
Methods: We analyzed data from the NIS database to investigate the association between obesity and abdominal NETs using patient information from 22,096 patient-discharges from January 1, 2009 to December 31, 2010.
Results: We demonstrate that obesity is strongly associated with decreased rates of inpatient mortality in patients with NET (OR = 0.6, multivariate P = 0.02) and that malnutrition is associated with nearly 5-fold higher odds of inpatient mortality (multivariate P < 0.0005). We did not find a statistical interaction between obesity and malnutrition; however, patients who were both malnourished and obese had a lower association with mortality risk than purely malnourished patients.
Conclusions: Our data suggests that nutritional status may be an important factor in inpatient mortality in patients with NETs with obesity being protective.
Keywords: Nationwide Inpatient Sample; abdominal neuroendocrine tumors; inpatient mortality.
Similar articles
-
The impact of body habitus on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis.J Neurosurg. 2017 Jul;127(1):36-46. doi: 10.3171/2016.4.JNS152562. Epub 2016 Jul 15. J Neurosurg. 2017. PMID: 27419827
-
Feeding the critically ill obese patient: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):95-109. doi: 10.11124/jbisrir-2015-2458. JBI Database System Rev Implement Rep. 2015. PMID: 26571286
-
Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis.Liver Int. 2016 Oct;36(10):1450-6. doi: 10.1111/liv.13137. Epub 2016 May 4. Liver Int. 2016. PMID: 27037497
-
Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors.Neuroendocrinology. 2020;110(5):430-442. doi: 10.1159/000503634. Epub 2019 Sep 25. Neuroendocrinology. 2020. PMID: 31550712 Review.
-
Nutrition and neuroendocrine tumors: An update of the literature.Rev Endocr Metab Disord. 2018 Jun;19(2):159-167. doi: 10.1007/s11154-018-9466-z. Rev Endocr Metab Disord. 2018. PMID: 30267297 Review.
Cited by
-
Inpatient outcomes comparing White and Black patients with obesity hospitalized for COVID-19 infection.J Natl Med Assoc. 2023 Apr;115(2):157-163. doi: 10.1016/j.jnma.2023.01.001. Epub 2023 Jan 21. J Natl Med Assoc. 2023. PMID: 36682964 Free PMC article.
-
Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms.Metabolites. 2022 Nov 21;12(11):1150. doi: 10.3390/metabo12111150. Metabolites. 2022. PMID: 36422290 Free PMC article. Review.
-
Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms.Biomedicines. 2022 Oct 21;10(10):2660. doi: 10.3390/biomedicines10102660. Biomedicines. 2022. PMID: 36289922 Free PMC article. Review.
-
Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms.Nutrients. 2020 Jun 30;12(7):1961. doi: 10.3390/nu12071961. Nutrients. 2020. PMID: 32630081 Free PMC article.
-
Nutritional and vitamin status in patients with neuroendocrine neoplasms.World J Gastroenterol. 2019 Mar 14;25(10):1171-1184. doi: 10.3748/wjg.v25.i10.1171. World J Gastroenterol. 2019. PMID: 30886501 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
